Across TCGA pan-cancer cohorts, VTI1BP4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of VTI1BP4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where VTI1BP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VTI1BP4 is over-expressed in tumor.

COAD and ESCA are the cancer types where VTI1BP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VTI1BP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.042	.028	2	view →
ESCA	Female	All	+0.229	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: VTI1BP4 RNA expression & survival · all VTI1BP4 data types